KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (ONC) Payables: 2015-2024

Historic Payables for BeOne Medicines (ONC) over the last 10 years, with Dec 2024 value amounting to $1.3 billion.

  • BeOne Medicines' Payables rose 289.22% to $1.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.2 billion, marking a year-over-year increase of 142.24%. This contributed to the annual value of $1.3 billion for FY2024, which is 298.76% up from last year.
  • Per BeOne Medicines' latest filing, its Payables stood at $1.3 billion for FY2024, which was up 298.76% from $315.1 million recorded in FY2023.
  • In the past 5 years, BeOne Medicines' Payables registered a high of $1.3 billion during FY2024, and its lowest value of $262.4 million during FY2021.
  • For the 3-year period, BeOne Medicines' Payables averaged around $622.1 million, with its median value being $315.1 million (2023).
  • As far as peak fluctuations go, BeOne Medicines' Payables spiked by 362.88% in 2020, and later slumped by 53.72% in 2021.
  • Over the past 5 years, BeOne Medicines' Payables (Yearly) stood at $567.0 million in 2020, then plummeted by 53.72% to $262.4 million in 2021, then grew by 12.34% to $294.8 million in 2022, then grew by 6.90% to $315.1 million in 2023, then spiked by 298.76% to $1.3 billion in 2024.